The European Association for the Study of the Liver (EASL) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) have issued a Position Paper, providing recommendations for clinicians caring for patients with liver diseases during the current pandemic…
Subsequent to the disruption caused by the COVID-19 pandemic, EASL and 32 other leading European medical associations – together forming the Biomedical Alliance in Europe (BioMed Alliance) – have submitted a joint statement to EU leaders. Together, we are calling…
13 March 2020 Given the ongoing developments with COVID-19, EASL has postponed the International Liver CongressTM (ILC 2020) that was scheduled for 15-19 April 2020 in London. Having reviewed the situation, and after taking extensive advice, we have decided on…
Over 600 delegates from 44 countries gathered in Prague at the EASL Liver Cancer Summit 2020 to discuss latest developments and the future of liver cancer research. Organised annually by EASL, the European Association for the Study of the Liver,…
Every year, the EASL Postgraduate course highlights many clinical practice dilemmas and engages the audience with world-renowned experts on how to make the best management decisions to help patients with liver disease. This year’s postgraduate course at the International Liver…
We’re pleased to announce the launch of our improved multi-disciplinary eLearning hub, EASL Campus, designed to help you develop your hepatology and liver-related disease knowledge through a variety of open-access, high quality and interactive resources tailored to your specialism and…
Four societies focused on liver disease research and treatment announced a global call-to-action initiative to simplify hepatitis C testing and treatment. BOSTON, 8 November 2019. The societies, in partnership with the Clinton Health Access Initiative (CHAI), launched the initiative at…
SHARE YOUR RESEARCH discuss your findings with other professionals NETWORK WITH EXPERTS interact with an international community & Key Opinion Leaders 9,000 experts in liver disease BOOST YOUR CAREER publication in the Journal of Hepatology supplement inclusion in the scientific…
Take advantage of the EASL funding and mentorship opportunities to attain the next level in your research. “The EASL Hepatology Fellowships are a great opportunity, not only to get financial support, but also to attend and present results at the…
On the 1st of September 2019, Professor Karl-Hermann Meyer zum Büschenfelde passed away shortly before his 90th birthday. He will be remembered as a pioneer in liver immunology and as one of the most prominent clinician scientists and mentors within…
